JP2019535788A5 - - Google Patents

Download PDF

Info

Publication number
JP2019535788A5
JP2019535788A5 JP2019528512A JP2019528512A JP2019535788A5 JP 2019535788 A5 JP2019535788 A5 JP 2019535788A5 JP 2019528512 A JP2019528512 A JP 2019528512A JP 2019528512 A JP2019528512 A JP 2019528512A JP 2019535788 A5 JP2019535788 A5 JP 2019535788A5
Authority
JP
Japan
Prior art keywords
alkyl
group
pharmaceutically acceptable
halo
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019528512A
Other languages
English (en)
Japanese (ja)
Other versions
JP7114591B2 (ja
JP2019535788A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/063231 external-priority patent/WO2018098412A1/en
Publication of JP2019535788A publication Critical patent/JP2019535788A/ja
Publication of JP2019535788A5 publication Critical patent/JP2019535788A5/ja
Application granted granted Critical
Publication of JP7114591B2 publication Critical patent/JP7114591B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019528512A 2016-11-28 2017-11-27 Gsk-3阻害剤 Active JP7114591B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662426631P 2016-11-28 2016-11-28
US62/426,631 2016-11-28
PCT/US2017/063231 WO2018098412A1 (en) 2016-11-28 2017-11-27 Gsk-3 inhibitors

Publications (3)

Publication Number Publication Date
JP2019535788A JP2019535788A (ja) 2019-12-12
JP2019535788A5 true JP2019535788A5 (https=) 2022-03-01
JP7114591B2 JP7114591B2 (ja) 2022-08-08

Family

ID=60655130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019528512A Active JP7114591B2 (ja) 2016-11-28 2017-11-27 Gsk-3阻害剤

Country Status (8)

Country Link
US (1) US10752609B2 (https=)
EP (1) EP3544613B1 (https=)
JP (1) JP7114591B2 (https=)
KR (1) KR102575990B1 (https=)
CN (1) CN110545817B (https=)
ES (1) ES2878078T3 (https=)
MA (1) MA46889A (https=)
WO (1) WO2018098412A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102455408B1 (ko) * 2016-11-28 2022-10-14 브리스톨-마이어스 스큅 컴퍼니 Gsk-3 억제제로서의 피리미딘 카르복스아미드
JP2022513967A (ja) * 2018-12-20 2022-02-09 アムジエン・インコーポレーテツド Kif18a阻害剤として有用なヘテロアリールアミド
AU2019401495B2 (en) 2018-12-20 2025-06-26 Amgen Inc. Heteroaryl amides useful as KIF18A inhibitors
JP7686559B2 (ja) 2018-12-20 2025-06-02 アムジエン・インコーポレーテツド Kif18a阻害剤
EP4007638A1 (en) 2019-08-02 2022-06-08 Amgen Inc. Pyridine derivatives as kif18a inhibitors
EP4007753B1 (en) 2019-08-02 2025-09-24 Amgen Inc. Kif18a inhibitors
CN116178281B (zh) * 2023-04-27 2023-07-21 中国药科大学 一种双功能免疫抑制剂及其制备方法和应用
EP4709712A1 (en) * 2023-05-10 2026-03-18 Blueprint Medicines Corporation Gsk3a inhibitors and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102438D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
MY150032A (en) * 2007-07-19 2013-11-29 Merck Sharp & Dohme Heterocyclic amide compounds as protein kinase inhibitors
WO2012024179A1 (en) * 2010-08-18 2012-02-23 Merck Sharp & Dohme Corp. Substituted amide derivatives as dgat-1 inhibitors
AU2014347027A1 (en) * 2013-11-06 2016-06-23 Bristol-Myers Squibb Company GSK -3 inhibitors
ES2693718T3 (es) * 2013-11-06 2018-12-13 Bristol-Myers Squibb Company Derivados de piridina sustituidos útiles como inhibidores de GSK-3
WO2016144797A1 (en) * 2015-03-06 2016-09-15 Alpharmagen, Llc Alpha 7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
KR102455408B1 (ko) * 2016-11-28 2022-10-14 브리스톨-마이어스 스큅 컴퍼니 Gsk-3 억제제로서의 피리미딘 카르복스아미드

Similar Documents

Publication Publication Date Title
JP2019535788A5 (https=)
JP2014507455A5 (https=)
JP2015509534A5 (https=)
JP2019513745A5 (https=)
JP2019517487A5 (https=)
JP2010501003A5 (https=)
JP2017537948A5 (https=)
JP2018505898A5 (https=)
JP2013537203A5 (https=)
RU2014145856A (ru) Азотсодержащее гетероциклическое соединение или его соль
HRP20180499T1 (hr) Spojevi i postupci za modulaciju kinaze, te odgovarajuće indikacije
JP2014506907A5 (https=)
JP2016532673A5 (https=)
US20140275080A1 (en) N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
JP2016512515A5 (https=)
JP2014527082A5 (https=)
JP2022515293A5 (https=)
JP2014521696A5 (https=)
JP2013525356A5 (https=)
JP2019535747A5 (https=)
JP2019525939A5 (https=)
RU2017116196A (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1
JP2015500223A5 (https=)
RU2016108038A (ru) Новые фталазиновые производные и способ их получения
JP2015500257A5 (https=)